Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Danese

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Alimentary Pharmacology & Therapeutics|February 16, 2011
Review article: infliximab for Crohn's disease treatment--shifting therapeutic strategies after 10 years of clinical experienceS Danese, J-F Colombel, W Reinisch, et al.
Drugs of Today (Barcelona, Spain : 1998)|April 17, 2015
Golimumab: clinical update on its use for ulcerative colitisD Gilardi, G Fiorino, M Allocca, et al.
Alimentary Pharmacology & Therapeutics|December 6, 2017
Systematic review with network meta-analysis: comparative assessment of tofacitinib and biological therapies for moderate-to-severe ulcerative colitisS Bonovas, T Lytras, G Nikolopoulos, et al.
Alimentary Pharmacology & Therapeutics|April 14, 2015
Systematic review with network meta-analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's diseaseL Moja, S Danese, G Fiorino, et al.
Alimentary Pharmacology & Therapeutics|March 16, 2013
Review article: the role of anti-TNF in the management of ulcerative colitis -- past, present and futureS Danese, J-F Colombel, L Peyrin-Biroulet, et al.
European Journal of Gynaecological Oncology|January 1, 1997
Weekly cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer: a well-tolerated alternativeG Giardina, G Richiardi, S Danese, et al.
Multiple Sclerosis and Related Disorders|December 22, 2022
Symptom burden, management and treatment goals of people with MS spasticity: Results from SEEN-MSS, a large-scale, self-reported surveyS D Newsome, B Thrower, B Hendin, et al.
La Radiologia Medica|May 1, 1994
[Survival and recurrence of endometrial adenocarcinoma]G Sinistrero, P Sismondi, P Zola, et al.
Alimentary Pharmacology & Therapeutics|March 7, 2017
Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel diseaseS Bonovas, G Fiorino, T Lytras, et al.
Current Medicinal Chemistry|February 5, 2011
Adalimumab in Crohn's disease: tips and tricks after 5 years of clinical experienceG Fiorino, H Szabò, W Fries, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Alimentary Pharmacology & Therapeutics|February 16, 2011
Review article: infliximab for Crohn's disease treatment--shifting therapeutic strategies after 10 years of clinical experienceS Danese, J-F Colombel, W Reinisch, et al.
Drugs of Today (Barcelona, Spain : 1998)|April 17, 2015
Golimumab: clinical update on its use for ulcerative colitisD Gilardi, G Fiorino, M Allocca, et al.
Alimentary Pharmacology & Therapeutics|December 6, 2017
Systematic review with network meta-analysis: comparative assessment of tofacitinib and biological therapies for moderate-to-severe ulcerative colitisS Bonovas, T Lytras, G Nikolopoulos, et al.
Alimentary Pharmacology & Therapeutics|April 14, 2015
Systematic review with network meta-analysis: comparative efficacy and safety of budesonide and mesalazine (mesalamine) for Crohn's diseaseL Moja, S Danese, G Fiorino, et al.
Alimentary Pharmacology & Therapeutics|March 16, 2013
Review article: the role of anti-TNF in the management of ulcerative colitis -- past, present and futureS Danese, J-F Colombel, L Peyrin-Biroulet, et al.
European Journal of Gynaecological Oncology|January 1, 1997
Weekly cisplatin as neoadjuvant chemotherapy in locally advanced cervical cancer: a well-tolerated alternativeG Giardina, G Richiardi, S Danese, et al.
Multiple Sclerosis and Related Disorders|December 22, 2022
Symptom burden, management and treatment goals of people with MS spasticity: Results from SEEN-MSS, a large-scale, self-reported surveyS D Newsome, B Thrower, B Hendin, et al.
La Radiologia Medica|May 1, 1994
[Survival and recurrence of endometrial adenocarcinoma]G Sinistrero, P Sismondi, P Zola, et al.
Alimentary Pharmacology & Therapeutics|March 7, 2017
Systematic review with meta-analysis: use of 5-aminosalicylates and risk of colorectal neoplasia in patients with inflammatory bowel diseaseS Bonovas, G Fiorino, T Lytras, et al.
Current Medicinal Chemistry|February 5, 2011
Adalimumab in Crohn's disease: tips and tricks after 5 years of clinical experienceG Fiorino, H Szabò, W Fries, et al.
Pageof 9